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nity study of a NT Aboriginal po
tion.7 More recently, a retrosp
study in one NT community 
LBW and later chronic disease in
tralian Aboriginal people8 and
gested LBW may be a contribu
the current high rates of type 2 d2) · 22 July 2013Objective:  To examine the relationships between birthweight, current size, and 
fasting glucose and fasting insulin levels in Aboriginal adolescents.
Design, participants and setting:  Longitudinal prospective study of a Northern 
Territory Aboriginal birth cohort of 686 Aboriginal babies born at the Royal 
Darwin Hospital between January 1987 and March 1990, and followed up 
between December 2006 and January 2008 in over 40 NT locations.
Main outcome measures:  Fasting insulin and glucose levels, adjusted for 
gestational age, sex and contemporary age.
Results:  Among the 134 participants with complete data, those with fetal 
growth restriction (FGR) or low birthweight (LBW) at birth were not overweight 
at 18 years. In these circumstances, birthweight showed a significant positively 
directed association with fasting glucose levels (P = 0.002). Current weight 
showed a significant and positively directed association with both fasting insulin 
(P < 0.001) and fasting glucose levels (P = 0.001), and current height showed a 
significant and positively directed association with insulin levels (P = 0.006).
Conclusions:  Birthweight was only positively associated with fasting glucose 
levels, with no association with fasting insulin levels. The high-risk combination 
for type 2 diabetes of LBW or FGR with later overweight or obesity was rare in 
this adolescent Aboriginal population.
Abstracthe
dia
lat
ent hypoth
T  concerning rise in type 2betes in Indigenous popu-ions continues, with differ-
eses put forward to explain
the phenomenon. International evi-
dence links the fetal nutrition proxies
of low birthweight (LBW) and fetal
growth restriction (FGR) to chronic
diseases in adult life.1 The develop-
mental origins of health and disease
(DOHaD) hypothesis states that
undernutrition in utero results in per-
manent changes through epigenetic
mechanisms that later influence dis-
ease development (http://www.mrc.
soton.ac.uk/dohad). The highest risk
for type 2 diabetes is reported when
LBW or FGR is followed by later over-
weight or obesity, suggesting a mis-
match between intrauterine and
postnatal nutrition.2
Despite recent improvements, Aus-
tralian Aboriginal LBW rates remain
double those of the non-Aboriginal
population.3 National Aboriginal rates
of FGR are unknown, but in a North-
ern Territory study, 25% of Aboriginal
newborns were defined as fetal
growth restricted.4
Concurrently, not only are Austral-
ian Indigenous rates of overweight
and obesity increasing — they cur-
rently range from 37% for ages 15–24
years to 74% for those aged over 55
years5 — but 10%–30% of Aboriginal
people are now estimated to have
type 2 diabetes.6
The high-risk combination of LBW
and later obesity has been shown to
be the greatest risk for elevated blood
pressure in a cross-sectional commu-
pula-
ective
linked
 Aus-
 sug-
tor to
iabe-
tes in the Aboriginal population.
Using data from a prospective life-
course Aboriginal birth cohort study,
our aim was to examine the relation-
ships of glucose and insulin metabo-
lism with birth and current adolescent
size.
Methods
We conducted a prospective life-
course study of an NT Aboriginal
birth cohort.
The recruitment and follow-up of
this birth cohort has been previously
published.9,10 In brief, 686 Aboriginal
babies out of a possible 1238 born at
the Royal Darwin Hospital (1987–
1990) were recruited into the study.
There were no significant differences
in the mean birthweight, sex ratio or
birthweight frequencies between
those recruited (686), those with ges-
tational age estimation (603) and
those not recruited. At follow-up
(2005–2008) in over 40 NT locations,
68 participants could not be found
(9.9%). Of the remainder, 27 had
died, 11 refused consent, 111 were
traced but were unable to be exam-
ined for logistical reasons,10 and 469
who had complete perinatal and ado-
lescent data were examined.
The birth measures of weight, gesta-
tional age estimations and follow-up
anthropometric measures have previ-
ously been described.4,10 Within 4 days
of birth, the same neonatal paediatri-
cian performed a gestational age
assessment using the Dubowitz scor-
ing system.11 LBW was defined as
birthweight < 2500g, FGR as birth-
weight < 10th percentile for gestational
age, and large for gestational age as
birthweight > 90th percentile for gesta-
tional age, using an Australian popula-
tion reference standard contemporary
with cohort recruitment.12
Adolescents were measured in light
clothing while barefoot. Height was
measured to the nearest millimetre
using a portable stadiometer and
weight was measured to the last com-
plete 0.1 kg with a digital electronic
scale (TBF-521, Tanita).
Participants were asked to fast from
midnight before the examination.
Blood samples were taken at the time
of examination, collected in fluoride
oxalate tubes after application of
anaesthetic cream to the venepunc-
ture site, separated after collection (for
a minority of samples, this was up to a
maximum of 2–3 hours) and trans-
ported in cold-boxes to Darwin.
Fasting glucose levels were meas-
ured enzymatically using a modular
analyser (Roche Diagnostics), fasting
insulin levels were measured by
Researchimmunoassay (AxSYM, Abbott Labo-
ratories), and glycated haemoglobin
concentrations by high-pressure liq-
uid chromatography (PDQ, Primus
Diagnostics). Insulin resistance was
estimated from fasting insulin and
g lucos e  con ce n tra t ion s  u s in g
homoeostatic model assessment
(HOMA-IR).13
Cross-sectional growth outcomes
were described by z scores for weight
for age (WAZ) and height for age
(HAZ) using the 2000 Centers for
Disease Control and Prevention
(CDC) sex-specific growth refer-
ence.14 Undernutrition was defined as
2 standard deviations (SDs) below
zero and overweight was defined as 2
SDs above zero, according to World
Health Organization criteria.15
Fasting was defined as an overnight
fast of 8 hours or more, and 134 partic-
ipants satisfied this criterion and had
complete perinatal and follow-up data.
Residence at the time of follow-up
was defined as remote (residence in
defined remote Aboriginal communi-
ties) or other (including the twin cities
of Darwin and Palmerston and the
greater Darwin area).
Statistical analysis
The clinical characteristics were sum-
marised as means (SD), and if not
normally distributed, as geometric
means (SD) and as category percent-
ages. Characteristics were compared
between sexes using the t test (for
normally distributed values) and the
2 test (for categorical values). Non-
normal data were transformed to
yield normal distribution before t tests
were performed.
Representativeness of the fasting
sample, as described above, was
tested using t, Wilcoxon and 2 tests,
depending on the distribution of the
test variable.
For analyses, birthweight, and ado-
lescent height, weight and body mass
index (BMI) were continuous varia-
bles, while birthweight for gestational
age was dichotomised at the 10th per-
centile for FGR and at the 90th per-
centile for large for gestational age.
The relationships of fasting insu-
lin, glucose and HOMA-IR measures
to the birth size and current adoles-
cent size were each analysed in
standard regression models using the
approach recommended by Lucas
and colleagues16 adjusted for gesta-
tional age, sex, and contemporary age
using Stata, version 11 (StataCorp).
In order to maintain the assump-
tions of regression-dependent varia-
bles, fasting insulin, glucose and
HOMA-IR values were transformed
using the natural log transformation.
Each outcome variable was tested in
separate univariate models for each of
the birth measures (eg, model 1), then
adjustment for height (eg, model 1a)
or weight (eg, model 1b) was added to
the model, then an interaction term
between the birth measures and ado-
lescent weight or height was added.
Lastly, the outcome variables were
tested in separate univariate models
for adolescent height (eg, model 3)
and weight (eg, model 4). Models
were separately analysed with cur-
rent-residence regression coefficients
and were then back-transformed
using exponentiation, presenting
ratios for ease of interpretation.
The percentage of total variance in the
outcome measures, accounted for by
early life size and later adolescent size,
were estimated by the difference in the
coefficients of determination (R2)
between fully adjusted birth models with
and without the measure of interest.
Ethics
The Human Research Ethics Commit-
tee of the Northern Territory Depart-
ment of Health and Families and
Menzies School of Health Research,
including the Aboriginal Ethics Sub
Committee, which has the power of
veto, approved the study. Written con-
sent was obtained in the form of an
itemised consent with participants
allowed to refuse individual procedures.
Results
One hundred and thirty-four partici-
pants had complete perinatal and fol-
low-up data and fasting insulin and
glucose measures. Box 1 shows the
comparison of the fasting subset with
the complete cohort and the subset of
participants who did not have fasting
values. This fasting subset was not
significantly different from the non-
fasting subset in the perinatal meas-
ures, the follow-up measures and the
levels of non-fasting biomarkers (gly-
cated haemoglobin and C-reactive
protein) associated with type 2 diabe-
tes. There were 59 males and 75
females with a mean age of 18.14 (SD,
1.1) years. The birth and adolescent
characteristics of this fasting subset
are shown in Box 2. As expected,
females were significantly shorter
(P< 0.01) and lighter (P< 0.01). Only
one participant had a fasting glucose
> 7 mmol/L and there were no partici-
pants with fasting glucose values of
6.1–6.9 mmol/L.
1 Comparison of the fasting sample and the original cohort: Aboriginal Birth 
Cohort 1987–2008
SD = standard deviation. * Unless otherwise speciﬁed. † t test unless otherwise speciﬁed. ‡ < 2500 g. 
§ 2 test. ¶ Wilcoxon test. ** Birthweight < 10th percentile for gestational age. †† Birthweight > 90th 
percentile for gestational age. ◆
Mean (SD)*
Characteristic
Original cohort with 
gestational age data 
(n = 603)
Fasting participants 
with complete data 
(n = 134) P†
Birthweight, g 3013 (654) 3027 (689) 0.78
Low birthweight‡ 18.2% 16.4% 0.54§
Gestational age, weeks 38.74 (1.96) 38.67 (2.11) 0.69¶
Fetal growth restriction** 27.5% 24.6% 0.39§
Large for gestational age†† 7.8% 9.7% 0.35§
Male 52.9% 44.0% 0.28§
Remaining original 
cohort at follow-up 
(n = 469)
Current age, years 18.30 (1.09) 18.14 (1.12) 0.06
Weight for age, z score  0.63 (1.62)  0.47 (1.63) 0.20
Height for age, z score  0.28 (0.92)  0.21 (0.97) 026
Body mass index, kg/m2 21.49 (5.63) 21.68 (5.47) 0.63
Glycated haemoglobin 5.20% (0.40%) 5.18% (0.42%) 0.49
C-reactive protein, mg/L 5.02 (7.48) 4.99 (7.78) 0.97113MJA 199 (2) · 22 July 2013
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2 Birth and current 
Characteristic
Perinatal
Birthweight, g
Gestational age, we
Low birthweight§
Fetal growth restrict
Large for gestationa
Adolescent
Age, years
Weight, kg
Weight for age, z sco
Weight for age, z sco
Height, cm
Height for age, z sco
Height for age, z sco
Body mass index, kg
Weight for age, z sco
Fasting glucose, mm
Fasting insulin, mU/
HOMA-IR
Glycated haemoglob
C-reactive protein, m
HOMA-IR = insulin resist
speciﬁed. † t test unless
** Birthweight > 90th peFor the fasting dataset, using the
international CDC reference,14 the
mean WAZ scores were negative for
both males and females. The propor-
tions of males and females with WAZ
<  2 (undernutrition) were 18.6% and
17.3%, respectively. At follow-up,
none of the 33 fasting adolescents
who had been fetal growth restricted
at birth had a WAZ > 2 (overweight/
obesity). Only one participant had a
WAZ > 1, with a similar profile occur-
ring for those who had LBW.
Birthweight had a significant posi-
tively directed association with fast-
ing glucose but not with fasting
insulin levels. For every kg increment
in birthweight, adolescent fasting
glucose levels rose by 7% (P= 0.002)
(Box 3). This positively directed asso-
ciation of birthweight with fasting
glucose levels remained after adjust-
ment for adolescent height or
weight, which accounted for 6% and
3% of the variation in fasting glucose
levels, respectively.
The significant association with
fasting glucose levels also remained
when birthweight was categorised as
birthweight for gestational age. For
adolescents who had been fetal
growth restricted at birth, fasting glu-
cose levels were 7% less than for
those who were not fetal growth
restricted at birth (P= 0.003), and
these relationships remained the
same after adjustment for adolescent
height and weight, again accounting
for 6% and 3% of the variation in
fasting glucose levels (Box 3).
Current height, weight and BMI
had significant and positively directed
associations with both fasting insulin
and glucose levels in univariate mod-
els, with the regression ratio and per-
centage of variation explained being
greatest for the fasting adolescent
insulin and HOMA-IR measures.
For every kg increment in weight,
cm increment in height or index point
in BMI, fasting insulin levels rose by
3%, 3% and 9%, respectively (Box 4),
and HOMA-IR by 3% (95% CI, 1.02–
1.04; P< 0.01), 3% (95% CI, 1.01–1.06;
P= 0.01) and 10% (95% CI, 1.08–
1.13), respectively (data for HOMA-
IR not shown), while for fasting glu-
cose, the changes were 0.1% increase
for every kg increment in weight,
0.2% for every cm increment in
height, and 0.7% for every index point
in BMI (Box 3).
Repeat analysis of all models with
the inclusion of the remote status var-
iable did not change any of the associ-
ations previously found. Regression
models (models 3, 4 and 5 in Box 3
and Box 4) of height, weight and BMI
were also reanalysed, with adjustment
for birthweight, which did not change
the results presented.
Apart from these main effects, there
were positive and significant interac-
tions between birthweight and height
for insulin (P= 0.006) and HOMA-IR
(P= 0.015) (data not shown). This
allows for an extra increment in insu-
lin and HOMA-IR values for partici-
pants who moved from higher
birthweight to higher adolescent
height. Hence, for a fixed current
height, those adolescents with higher
birthweights had higher measures of
insulin and HOMA-IR values.
Discussion
In this adolescent cohort, there were
no negatively directed associations
between birthweight and either fasting
glucose, insulin concentrations or the
insulin-resistance measure, with no
evidence of the U-shaped associations
described for populations with similar
high rates of type 2 diabetes in adult
life. A positively directed association
occurred for birthweight with fasting
glucose levels. Consistent with these
findings, those adolescents who had
been fetal growth restricted at birth
had lower fasting glucose concentra-
tions. In contrast, even in this young
and lean population, there were posi-
tively directed associations of current
adolescent height and weight with
fasting glucose and insulin concentra-
tions and the insulin-resistance meas-
ure, albeit of a relatively trivial
magnitude for fasting glucose. For fast-
ing glucose levels, the effect of birth-
weight and current weight was similar
(R2, 0.070 v 0.076), but for fasting insu-
lin levels, the effect of current weight
was considerably stronger than birth-
weight (R2, 0.299 v 0.019). These over-
all findings are similar to findings for
these Aboriginal cohort participants at
11 years of age.17
The proportions of males and
females with undernutrition (WAZ< 2)
were 18.6% and 17.3%, respectively,
which far exceeded the expected 2.3%
using the CDC sex-specific growth ref-
adolescent characteristics of 134 fasting Aboriginal adolescents
Mean (SD)*
Total (n = 134) Male (n = 59) Female (n = 75) P†
3027 (689) 3178 (730) 2908 (635) 0.02
eks 38.7 (2.1) 38.7 (2.4) 38.6 (1.9) 0.79‡
16.4% 10.2% 21.3% 0.08
ion¶ 24.6% 20.3% 28.0% 0.31
l age** 9.7% 11.9% 8.0 0.56
18.14 (1.12) 18.11 (1.01) 18.17 (1.20) 0.77
61.49 (20.06) 70.37 (23.74) 54.5 (13.0) < 0.01‡
re  0.47 (1.62)  0.24 (1.74)  0.65 (1.52) 0.15
re <  21 17.9% 18.6% 17.3% 0.84
167.33 (9.26) 174.41 (7.61) 161.76 (6.12) < 0.01
re  0.21 (0.97)  0.21 (1.02)  0.21 (0.95) 0.98
re  214 3.0% 5.1% 1.3% 0.32††
/m2 21.68 (5.47) 22.83 (6.35) 20.78 (4.50) 0.04‡
re > 215 6.7% 13.5% 1.3% 0.09
ol/L 4.64 (0.59) 4.78 (0.46) 4.53 (0.65) 0.01‡
L 8.36‡‡ (2.40) 7.47‡‡ (2.54) 9.16‡‡ (2.28) 0.19
1.71‡‡ (2.53) 1.58‡‡ (2.71) 1.83‡‡ (2.39) 0.38
in 5.16%‡‡ (1.08%) 5.19%‡‡ (1.08%) 5.14%‡‡ (1.08%) 0.48
g/L 1.88‡‡ (4.84) 2.03‡‡ (4.07) 1.78‡‡ (5.53) 0.64
ance estimated using homoeostatic model assessment. SD = standard deviation. * Unless otherwise 
 otherwise speciﬁed. ‡ Unequal t test. § < 2500 g. ¶ Birthweight < 10th percentile for gestational age. 
rcentile for gestational age. †† Fisher’s exact test. ‡‡ Geometric mean. ◆2) · 22 July 2013
Researcherence.14 Hence, compared with this
international reference, there was a
marked excess of undernutrition in
this cohort. Importantly, the findings
of no associations between LBW and
FGR with higher fasting adolescent
insulin and glucose levels were con-
trary to the DOHaD hypothesis, and
suggest that the adverse effects of
poor fetal nutrition may be concealed
by the persistent undernutrition in
these Aboriginal adolescents.
The main strength of this study is
that the data have been prospec-
tively collected from a contemporary
Australian Indigenous population.
This is in contrast to many of the
other studies examining the DOHaD
hypothesis, which are retrospective
studies.
Unusually for this type of cohort, at
the time of recruitment less than 10% of
mothers had homebirths.9 The single-
point tertiary hospital recruitment
meant birth measurements were stand-
ardised, and reliable gestational age
estimations were all made by the one
neonatal paediatrician within 4 days of
birth. Hence, the better fetal growth
surrogate of birthweight adjusted for
gestational age was available for analy-
sis. Further, all follow-up biological
measures were directly collected.
The difficulty in obtaining reliable
fasting blood samples in the field is
reflected in the small sample size.
However, a number of significant
associations were present despite this
sample size. A further limitation due
to the age of participants is the neces-
sity of using intermediary biomarkers
of diabetes instead of the preferred
specific disease end point. Socioeco-
nomic status (SES) factors are poten-
tial confounders in this study and
standard SES indicators were col-
lected, such as years of schooling,
house ownership and employment.
There are limitations of standard
measures in capturing the multi-
dimensional differences within popu-
la tions  similar  to  this  cohort
population.18 In the absence of ade-
quate discriminatory measures of SES,
we used only remote current residence
as an objective surrogate measure of
SES. Including this variable made only
a limited difference to the significance
of one association.
Our findings are in contrast to the
predominant literature of the DOHaD
hypothesis describing inverse associa-
tions between birthweight and later
fasting insulin and glucose levels.
While these reports are mainly retro-
spective studies from developed popu-
lations,1 similar findings have been
reported from Aboriginal populations19
and five low- or middle-income-coun-
try birth cohorts.20
Similar findings to our study have
been reported in a young lean popu-
lation of Guatemalan men and
women at a mean age of 24 years.21
Further, in the Newcastle Thousand
Families Study, at 49–51 years of age,
adult lifestyle factors explained larger
proportions of variances for fasting
and 2-hour glucose compared with
early-life measures.22,23 A contempo-
rary study of British children, based
on maternal recall of birthweight,
reports current size as the main
determinant of insulin and glucose
concentrations in childhood.24
The growth outcomes in our study
suggest that a major nutritional mis-
match between fetal and adolescent
life has not occurred. It is likely that the
permanent changes in response to
undernutrition in utero have remained
appropriate in this undernourished
adolescent population with low rates
of the high-risk combination of LBW-
or FGR-associated later obesity or
overweight.
Given the high prevalence of over-
weight and obesity currently seen in
the adult Aboriginal population,6 it is
likely that the growth trajectory will
positively change in this cohort and
the high-risk combination for chronic
disease of LBW or FGR followed by
overweight or obesity will become
more common over the next decade.
Then the relationships of LBW or FGR
with chronic biomarkers may become
apparent, consistent with the DOHaD
hypothesis. With the follow-up of this
cohort at the age of 26 years currently
underway, we are well placed to
determine if and when the effects of
poor intrauterine nutrition are poten-
tiated by the onset of overweight and
obesity.
4 Size at birth and adolescent height and weight: relationships with fasting insulin 
concentrations (mU/L) among Aboriginal adolescents (n = 134)*
Model Ratio 95% CI P R2†
Model 1: birthweight, kg 1.28 0.94–1.73 0.112 0.019
Model 1a: adjusted for child height 1.12 0.82–1.54 0.471 0.004
Model 1b: adjusted for child weight 0.87 0.66–1.15 0.326 0.005
Model 2: FGR‡ v non-FGR§ 0.92 0.65–1.31 0.656 0.002
Model 2a: adjusted for child height 1.01 0.71–1.43 0.961 0
Model 2b: adjusted for child weight 1.27 0.94–1.71 0.120 0.012
Model 3: current height, cm 1.03 1.01–1.05 0.006 0.055
Model 4: current weight, kg 1.03 1.02–1.03 < 0.001 0.299
Model 5: body mass index 1.09 1.07–1.12 < 0.001 0.307
FGR = fetal growth restriction. *All models adjusted for gestational age, sex and contemporary age. 
† Difference between fully adjusted birth models with and without the measure of interest. 
‡ Birthweight< 10th percentile for gestational age. § Birthweight 10th percentile for gestational age. ◆
3 Size at birth and adolescent height and weight: relationships with fasting glucose 
(mmol/L) concentrations among Aboriginal adolescents (n = 134)*
Model Ratio 95% CI P R2†
Model 1: birthweight, kg 1.07 1.03–1.11 0.002 0.070
Model 1a: adjusted for child height 1.07 1.02–1.11 0.005 0.057
Model 1b: adjusted for child weight 1.05 1.00–1.09 0.035 0.030
Model 2: FGR‡ v non-FGR§ 0.93 0.89–0.98 0.003 0.062
Model 2a: adjusted for child height 0.93 0.89–0.98 0.006 0.055
Model 2b: adjusted for child weight 0.95 0.90–0.99 0.028 0.033
Model 3: current height, cm 1.002 0.99–1.01 0.179 0.013
Model 4: current weight, kg 1.001 1.001–1.003 0.001 0.076
Model 5: body mass index 1.007 1.003–1.01 < 0.001 0.089
FGR =fetal growth restriction. *All models adjusted for gestational age, sex and contemporary age. 
†Difference between fully adjusted birth models with and without the measure of interest. 
‡Birthweight<10th percentile for gestational age. §Birthweight 10th percentile for gestational age. ◆115MJA 199 (2) · 22 July 2013
Research
MJA 199 (116In the meantime, our findings sug-
gest that the current high rates of type
2 diabetes observed in the adult Abo-
riginal population are more likely to
be decreased by strategies targeted to
improve lifestyle factors in childhood
and adolescence, rather than those
focusing on improving birthweight
alone.
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